Synapse - Joshua Chaim

Results (26)

A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer

Journal Article

Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
European Urology Oncology (2024)

Fulltext@MSK | Save

Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade

Journal Article

Ged, Y.; Sanchez, A.; Patil, S.; Knezevic, A.; Stein, E.; Petruzella, S.; Weiss, K.; Duzgol, C.; Chaim, J.; Akin, O.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Local extent of prostate cancer at MRI versus prostatectomy histopathology: Associations with long-term oncologic outcomes

Journal Article

Wibmer, A. G.; Nikolovski, I.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Sala, E.; Carlsson, S. V.; Fine, S. W.; Kattan, M. W.; Hricak, H.; more...
Radiology (2022)

Fulltext@MSK | Save

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

Journal Article

Sarfaty, M.; Whiting, K.; Teo, M. Y.; Lee, C. H.; Peters, V.; Durocher, J.; Regazzi, A. M.; McCoy, A. S.; Hettich, G.; Jungbluth, A. A.; more...
Cancer Medicine (2021)

Fulltext@MSK | Save

Oncologic outcomes after localized prostate cancer treatment: Associations with pretreatment prostate magnetic resonance imaging findings

Journal Article

Wibmer, A. G.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Nincevic, J.; Nikolovski, I.; Sala, E.; Gonen, M.; Carlsson, S. V.; Fine, S. W.; more...
Journal of Urology (2021)

Fulltext@MSK | Save

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial

Journal Article

Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
Cancer (2020)

Fulltext@MSK | Save

DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy

Journal Article

Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

A phase II trial of durvalumab (MEDI4736) and tremelimumab in metastatic, nontransitional cell carcinoma of the urothelial tract

Meeting Abstract

Sarfaty, M.; Ostrovnaya, I.; Teo, M. Y.; Iyer, G.; Lee, C. H.; Peters, V.; Durocher, J.; Regazzi, A. M.; McCoy, A. S.; Hettich, G.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents

Meeting Abstract

Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)

Meeting Abstract

Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save